-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Anning shares disclosed its annual report on March 31, 2021.
Anning shares disclosed its annual report on March 31, 2021.
The expense ratio decreased by 4.
The company's operating cost in 2020 is 580 million, a year-on-year increase of 6%, which is lower than the 19% growth rate of operating income, resulting in a 4.
"Titanium Concentrate" has a greater contribution to revenue in this period
From the perspective of business structure, "titanium concentrate" is the main source of corporate operating income.
From the perspective of business structure, "titanium concentrate" is the main source of corporate operating income.
Specifically, the operating income of "titanium concentrate" was 850 million, the revenue accounted for 52.
6%, and the gross profit margin was 76.
5%.